IBDLink is a global initiative created and funded by Pfizer, which seeks to advance care for patients with ulcerative colitis (UC).
We believe this goal can be achieved by focusing on:
- Encouraging multidisciplinary management
- Enhancing dialogues between physicians and patients
- Establishing patient-centric approaches
- Addressing gaps in care
As a part of the IBDLink initiative, this site was created to assist gastroenterologists (GIs) in meeting the needs of their patients with UC.
Multidisciplinary management focuses on the emotional, professional, and social effects of GI disorders in the patient’s
life—including the role other HCPs (social workers, psychologists, dietitians, therapists) can play in supporting treatment of UC.
Physicians can enhance the dialogue by understanding patients’ concerns and values, providing what they need and what they want to know, while empowering them to take an active role in their overall disease management.
Learn From Global GI Leaders
IBDLink is an initiative of Pfizer, which is led by a global committeea that aims to identify and provide educational content focused on supporting shared decision-making between HCPs and the patients under their care.